| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0302 | 6,8-diprenyleriodictyol | Antioxidant, inhibiting Cu(2+)-mediated oxidation of human low density lipoprotein (LDL) |
|
| DCC0303 | 65-a11 | Novel methuselah (Mth)-specific antagonist |
|
| DCC0304 | 680sir | Novel fluorescent probe for near-IR live-cell super-resolution imaging |
|
| DCC0305 | 6-alkynyl-fucose | Widely used fucosylation probe, strongly inhibiting fucosylation and GDP-fucose synthetase FX, halting hepatoma invasion |
|
| DCC0306 | 6-benzylthioinosine | Broad-spectrum metabolic inhibitor, inhibiting glucose uptake, decreasing glycolysis and ATP with minimal changes in ROS and mitochondrial respiration |
|
| DCC0307 | 6beta-acetoxy-7alpha-hydroxyroyleanone | Natural blocker of Kv1.2 channels, not involving direct occlusion of the outer pore but depending on C-type inactivation |
|
| DCC0308 | 6-bn-adp | Precursor for radio-labelled triphosphate to be used in chemical genetics approach |
|
| DCC0309 | 6-bn-atp | ATP analog for specific interaction with modified receptor proteins in chemical genetics approach |
|
| DCC0310 | 6br-6a | Novel inhibitor of STAT3 activation, suppressing proliferation, inducing cell cycle arrest and apoptosis in breast cancer |
|
| DCC0311 | 6-bz-8-pip-camp | Membrane-permeant activator of cAMP-dependent protein kinase (PKA), selectively for site A-I of PKA |
|
| DCC0312 | 6-cl-imt | Novel selective ligand of the Transport Inhibitor Resistant 1 (TIR1) |
|
| DCC0313 | 6cl-tgq | Novel potent activator of insulin receptor (IR) signaling in cell models and insulin-responsive tissues, alleviating diabetes |
|
| DCC0314 | 6-deoxyglucose-diphyllin | Novel potent blocker of ZIKV infection at a pre-fusion step or during fusion |
|
| DCC0315 | 6f-trp | Novel probe for detecting tryptophan metabolites in ex vivo tissue samples via 19F nuclear magnetic resonance |
|
| DCC0316 | 6-hydroxymyosmine | Nornicotine metabolite |
|
| DCC0317 | 6jc48-1 | Novel inhibitor of Lipid II with less cytotoxicity and improved pharmacokinetic profile |
|
| DCC0318 | 6k-f17 TFA salt | Novel cationic antimicrobial peptide (CAP) |
|
| DCC0319 | 6-mbc-camp | Selective agonist of protein kinase A, strongly preferring the A site of cAK II |
|
| DCC0320 | 6n-fam | Novel high-affinity NR5A probe for fluorescence polarization competition assays, tightly binding the NR5A receptors and detecting direct binding of synthetic and phospholipid ligands |
|
| DCC0321 | 6-nonylpyridine-2,4-diol | Novel highly potent agonist of GPR84 |
|
| DCC0322 | 6-o-acetylglycitin | Metabolite of soy isoflavone, preventing bone loss and reversing the unfavorable changes of lipid metabolism |
|
| DCC0323 | 6-oh-bta-0 | The precursor for preparing 11C-PiB, a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis |
|
| DCC0324 | 6pgd-in-s3 | Novel inhibitor of 6-phosphogluconate dehydrogenase (6PGD) |
|
| DCC0325 | 6'-ß-fluoro-homoaristeromycin | Novel potent inhibitor of chikungunya virus (CHIKV) replication |
|
| DCC0326 | 6-thioguanosine Monophosphate Sodium Salt | Thiopurine metabolite, blocking activation of GTPase Rac1 in T lymphocytes |
|
| DCC0327 | 6α-methylprednisone | Glucocorticoid with anti-inflammatory and immunosuppressive activities |
|
| DCC0328 | 7-(r)-hydroxystearic Acid | Novel potent cell growth inhibitor, suppressing the cytokine-Induced β-cell apoptosis |
|
| DCC0329 | 7,8,3'-trihydroxyflavone | Agonist of tyrosine receptor kinase B (TrkB) |
|
| DCC0330 | 780-5fu | Novel NIR fluorescent heptamethine cyanine dye IR-780 and 5FU conjugate, exhibiting enhanced CSCs-targeting therapeutic effects |
|
| DCC0331 | 7alpha-acetoxy-6beta-hydroxyroyleanone | Natural antiplasmodial agent |
|
